Associated Papers
Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemia.
Sommer C et al.
Scientific Reports, 2025
40987801 (PubMed )
Supplement: 41598_2025_20589_MOESM1_ESM.pdf
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.
Heyes E et al.
Nature Communications, 2023
37794021 (PubMed )
Supplement: 41467_2023_41927_MOESM1_ESM.pdf
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.
Mannelli F et al.
Haematologica, 2017
28250006 (PubMed )
Supplement: 2016.151910.MANNELLI_SUPPL.pdf
Select a paper to view details